WU
30
6
PYPL
37
-4
RSG
76
3
KLAC
61
-4
XRAY
16
-7
EMR
50
2
ALLE
35
10
SO
73
3
MRO
42
6
APH
64
-4
TGT
45
3
GPC
38
3
CINF
53
6
GM
65
4
SHW
59
-2
MKC
35
2
GWW
44
-2
EQR
67
2
BEN
48
4
KMI
63
8
WU
30
6
PYPL
37
-4
RSG
76
3
KLAC
61
-4
XRAY
16
-7
EMR
50
2
ALLE
35
10
SO
73
3
MRO
42
6
APH
64
-4
TGT
45
3
GPC
38
3
CINF
53
6
GM
65
4
SHW
59
-2
MKC
35
2
GWW
44
-2
EQR
67
2
BEN
48
4
KMI
63
8
Financhill
Back

Appili Therapeutics Vs. First Solar Industry Stock Comparison

Sell
37

APLIF
Appili Therapeutics

Last Price:
0.03
Seasonality Move:
23.06%
Buy
60

FSLR
First Solar

Last Price:
256.79
Seasonality Move:
5.94%
Sell
37
Appili Therapeutics (APLIF) is a Sell

Is Appili Therapeutics a Buy, Sell or Hold?

  • The current Appili Therapeutics [APLIF] share price is $0.03. The Score for APLIF is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • APLIF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
First Solar (FSLR) is a Buy

Is First Solar a Buy, Sell or Hold?

  • The current First Solar [FSLR] share price is $256.70. The Score for FSLR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • FSLR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLIF Stock Price Chart

What is Appili Therapeutics's stock price today?

  • The Appili Therapeutics share price today is $0.03
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLIF is experiencing slight buying pressure.

FSLR Stock Price Chart

What is First Solar's stock price today?

  • The First Solar share price today is $256.70
    The current trend is moderately bearish and FSLR is experiencing slight selling pressure.

APLIF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 37.14 Sell
Chaikin Money Flow: -45000 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.03 - 0.03) Sell
Bollinger Bands (100): (0.03 - 0.03) Sell

FSLR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.66 Buy
Relative Strength Index (14 RSI): 51.06 Buy
Chaikin Money Flow: -553192 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

APLIF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.03 Sell
20-day SMA: 0.03 Sell
50-day SMA: 0.03 Sell
200-day SMA: 0.03 Sell
8-day EMA: 0.03 Sell
20-day EMA: 0.03 Sell
50-day EMA: 0.03 Sell
200-day EMA: 0.03 Sell

FSLR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 265.72 Sell
20-day SMA: 273.02 Sell
50-day SMA: 224.84 Buy
200-day SMA: 173.66 Buy
8-day EMA: 264.32 Sell
20-day EMA: 261.39 Sell
50-day EMA: 234.3 Buy
200-day EMA: 189.12 Buy

Appili Therapeutics Earnings Growth & APLIF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

First Solar Earnings Growth & FSLR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.82 per share, an increase next quarter of $0.92 per share, an increase this year of $5.78 per share, and an increase next year of $8.27 per share.

Appili Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

First Solar Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):